2L
EGRX

25 LLC’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

25 LLC’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18
Closed -$526 – 711
2023
Q1 		$526 Buy
+18
New +$526 ﹤0.01% 330